The Crisis in Antibiotic Resistance

The synthesis of large numbers of antibiotics over the past three decades has caused complacency about the threat of bacterial resistance. Bacteria have become resistant to antimicrobial agents as a result of chromosomal changes or the exchange of genetic material via plasmids and transposons. Streptococcus pneumoniae, Streptococcus pyogenes, and staphylococci, organisms that cause respiratory and cutaneous infections, and members of the Enterobacteriaceae and Pseudomonas families, organisms that cause diarrhea, urinary infection, and sepsis, are now resistant to virtually all of the older antibiotics. The extensive use of antibiotics in the community and hospitals has fueled this crisis. Mechanisms such as antibiotic control programs, better hygiene, and synthesis of agents with improved antimicrobial activity need to be adopted in order to limit bacterial resistance.

[1]  C. Soussy,et al.  Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France , 1992, Antimicrobial Agents and Chemotherapy.

[2]  R. Gaynes,et al.  A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. , 1992 .

[3]  J. Burke,et al.  Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients. , 1992 .

[4]  H. Neu New macrolide antibiotics: azithromycin and clarithromycin. , 1992, Annals of internal medicine.

[5]  E. Wong,et al.  Infections Due to Beta-Lactamase-producing, High-Level Gentamicin-resistant Enterococcus faecalis , 1992, Annals of Internal Medicine.

[6]  K. Hiramatsu,et al.  Survey of methicillin-resistant clinical strains of coagulase-negative staphylococci for mecA gene distribution , 1992, Antimicrobial Agents and Chemotherapy.

[7]  T. Klaukka,et al.  Resistance to erythromycin in group A streptococci. , 1992, The New England journal of medicine.

[8]  D. Aubel,et al.  R-plasmid-encoded adhesive factor in Klebsiella pneumoniae strains responsible for human nosocomial infections , 1992, Infection and immunity.

[9]  R. Gaynes,et al.  Resistance to Imipenem Among Selected Gram-Negative Bacilli in the United States , 1992, Infection Control & Hospital Epidemiology.

[10]  H. Neu,et al.  Quinolone antimicrobial agents. , 1992, Annual review of medicine.

[11]  G. Laible,et al.  Five independent combinations of mutations can result in low-affinity penicillin-binding protein 2x of Streptococcus pneumoniae , 1991, Journal of bacteriology.

[12]  C. Walsh,et al.  Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. , 1991, Biochemistry.

[13]  C. Sanders New β-Lactams: New Problems for the Internist , 1991 .

[14]  V L Yu,et al.  Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. , 1991, Annals of internal medicine.

[15]  L. Peterson,et al.  Uptake of 3H-norfloxacin in methicillin-resistant Staphylococcus aureus. , 1991, The Journal of antimicrobial chemotherapy.

[16]  G. Jacoby,et al.  More extended-spectrum beta-lactamases , 1991, Antimicrobial Agents and Chemotherapy.

[17]  J. Zhou,et al.  Horizontal transfer of multiple penicillin‐binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae , 1991, Molecular microbiology.

[18]  M. Leinonen,et al.  Antigenic variation of penicillin-binding proteins from penicillin-resistant clinical strains of Streptococcus pneumoniae. , 1991, The Journal of infectious diseases.

[19]  M. Leinonen,et al.  Variability of penicillin-binding proteins from penicillin-sensitive Streptococcus pneumoniae. , 1991, The Journal of infectious diseases.

[20]  A. Tomasz,et al.  Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. , 1991, The Journal of infectious diseases.

[21]  L. Bryan,et al.  Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy , 1991, Antimicrobial Agents and Chemotherapy.

[22]  M. Arthur,et al.  Structural relationship between the vancomycin resistance protein VanH and 2-hydroxycarboxylic acid dehydrogenases. , 1991, Gene.

[23]  R. Leclercq,et al.  Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification , 1991, Antimicrobial Agents and Chemotherapy.

[24]  P. M. Terry,et al.  Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. , 1991, The Journal of infectious diseases.

[25]  B. Plikaytis,et al.  Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group. , 1991, The Journal of infectious diseases.

[26]  L. Gutmann,et al.  Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem , 1991, Antimicrobial Agents and Chemotherapy.

[27]  H. Nikaido,et al.  Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins , 1991, Antimicrobial Agents and Chemotherapy.

[28]  A. Tomasz,et al.  Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. , 1991, The Journal of infectious diseases.

[29]  C. Walsh,et al.  Identification of vancomycin resistance protein VanA as a D-alanine:D-alanine ligase of altered substrate specificity. , 1991, Biochemistry.

[30]  J. Miller,et al.  Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. , 1991, Annals of internal medicine.

[31]  A. Fenoll,et al.  Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. , 1991, Reviews of infectious diseases.

[32]  P. Courvalin Resistance of enterococci to glycopeptides , 1990, Antimicrobial Agents and Chemotherapy.

[33]  G. Doern,et al.  Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States , 1990, Antimicrobial Agents and Chemotherapy.

[34]  L. Gutmann,et al.  Presence of an additional penicillin-binding protein in methicillin-resistant Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, and Staphylococcus simulans with a low affinity for methicillin, cephalothin, and cefamandole , 1990, Antimicrobial Agents and Chemotherapy.

[35]  M. Sachdeva,et al.  Binding of β-Lactam Antibiotics to Penicillin-Binding Proteins in Methicillin-Resistant Staphylococcus aureus , 1990 .

[36]  G. Phillips,et al.  Erythromycin-resistant Streptococcus pyogenes. , 1990, The Journal of antimicrobial chemotherapy.

[37]  S. Wallander,et al.  Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centres. , 1990, Scandinavian journal of infectious diseases.

[38]  R. Wallace,,et al.  BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata , 1989, Antimicrobial Agents and Chemotherapy.

[39]  J. Quinn,et al.  Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae , 1989, Antimicrobial Agents and Chemotherapy.

[40]  G. Jacoby,et al.  Extended-spectrum beta-lactamases , 1989, Antimicrobial Agents and Chemotherapy.

[41]  T. Nicas,et al.  Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis , 1989, Antimicrobial Agents and Chemotherapy.

[42]  D. Shlaes,et al.  Inducible resistance to vancomycin in Enterococcus faecium D366. , 1989, The Journal of infectious diseases.

[43]  D. Shlaes,et al.  Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256 , 1989, Antimicrobial Agents and Chemotherapy.

[44]  J. Duval,et al.  Transferable vancomycin and teicoplanin resistance in Enterococcus faecium , 1989, Antimicrobial Agents and Chemotherapy.

[45]  B. Berger-Bächi,et al.  Cloning and expression of methicillin resistance from Staphylococcus epidermidis in Staphylococcus carnosus , 1988, Antimicrobial Agents and Chemotherapy.

[46]  G. Eliopoulos,et al.  High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium , 1988, Antimicrobial Agents and Chemotherapy.

[47]  J. Duval,et al.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. , 1988, The New England journal of medicine.

[48]  B. D. Davis The lethal action of aminoglycoside , 1988 .

[49]  G. Gerbaud,et al.  Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. , 1988, Reviews of infectious diseases.

[50]  L. Bryan General mechanisms of resistance to antibiotics. , 1988, The Journal of antimicrobial chemotherapy.

[51]  C. Sanders,et al.  Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins. , 1988, Reviews of infectious diseases.

[52]  M. Zervos,et al.  Gentamicin resistance plasmids of enterococci from diverse geographic areas are heterogeneous. , 1988, The Journal of infectious diseases.

[53]  B. Spratt,et al.  Penicillin-binding proteins of gram-negative bacteria. , 1988, Reviews of infectious diseases.

[54]  H. Chambers,et al.  Methicillin-resistant staphylococci , 1988, Clinical Microbiology Reviews.

[55]  M. Arthur,et al.  Evidence for natural gene transfer from gram-positive cocci to Escherichia coli , 1988, Journal of bacteriology.

[56]  S. Dipp,et al.  Epidemiology of rob beta-lactamase among ampicillin-resistant Haemophilus influenzae isolates in the United States. , 1988, The Journal of infectious diseases.

[57]  P. Larsson,et al.  Erythromycin-resistant beta-hemolytic streptococci group A in Göteborg, Sweden. , 1988, Scandinavian journal of infectious diseases.

[58]  M. Arthur,et al.  Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses. , 1987, The Journal of antimicrobial chemotherapy.

[59]  H. Chambers Coagulase-negative staphylococci resistant to beta-lactam antibiotics in vivo produce penicillin-binding protein 2a , 1987, Antimicrobial Agents and Chemotherapy.

[60]  V. Yu,et al.  Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum. , 1987, Archives of internal medicine.

[61]  M. Zervos,et al.  Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. , 1987, Annals of internal medicine.

[62]  P. Gilligan,et al.  Emergence of vancomycin resistance in coagulase-negative staphylococci. , 1987, The New England journal of medicine.

[63]  S. Morse,et al.  High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant , 1986, Antimicrobial Agents and Chemotherapy.

[64]  J. Brunton,et al.  Origin of small beta-lactamase-specifying plasmids in Haemophilus species and Neisseria gonorrhoeae , 1986, Journal of bacteriology.

[65]  A. Malmborg The renaissance of erythromycin. , 1986, The Journal of antimicrobial chemotherapy.

[66]  K. Ubukata,et al.  Occurrence of a beta-lactam-inducible penicillin-binding protein in methicillin-resistant staphylococci , 1985, Antimicrobial Agents and Chemotherapy.

[67]  B. Murray,et al.  Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis. , 1983, The Journal of clinical investigation.

[68]  B. Murray,et al.  Enterococci from Bangkok, Thailand, with high-level resistance to currently available aminoglycosides , 1983, Antimicrobial Agents and Chemotherapy.

[69]  K. Holmes,et al.  Epidemiology of penicillinase-producing Neisseria gonorrhoeae infections: analysis by auxotyping and serogrouping. , 1982, The New England journal of medicine.

[70]  J. Ward Antibiotic-resistant Streptococcus pneumoniae: clinical and epidemiologic aspects. , 1981, Reviews of infectious diseases.

[71]  W. Schaffner,et al.  Evolution of antimicrobial resistance and nosocomial infection. Lessons from the Vanderbilt experience. , 1981, The American journal of medicine.

[72]  K. Fujita,et al.  Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. , 1979, American journal of diseases of children.